As Moderna and Pfizer feud, what is future of access to mRNA technology?
Zain Rizvi of Public Citizen talks about the legal battle between Moderna and Pfizer over patents on mRNA technology. He also addresses the question of access to this vital technology that is used to make COVID-19 vaccines and other medical products
The people of the world vs Pfizer Inc.
During the Covid-19 pandemic, Pfizer has used every opportunity to maximize its profits, even if this meant reduced access to life-saving medical products for most of the world. The same is about to happen in the case of Paxlovid, the company’s Covid-19 oral treatment
COVID-19 vaccines: Differences, costs, and challenges
The COVID-19 pandemic saw the fastest development of a vaccine ever, with a number of research collaborations making this feat possible. But many challenges also remain
Good news on vaccines but what about its delivery?
If we plan to vaccinate the entire Indian people, the states need to be involved in a big way, however, the Modi government has so far centralized all aspects of the management of the epidemic, treating it only as an administrative problem.
- Google employees lead sit-ins protesting company’s complicity in genocide
- Israeli tourists attack vigil in Cusco in support of Palestine
- During Red April, Brazil’s MST restates the importance of agrarian reform
- German authorities’ crackdown on Palestine Conference sparks widespread outrage
- As elections approach, India’s farmers count government’s broken promises
